IMP
Process View
modification of morphology or physiology of other organism
The process in which an organism effects a change in the structure or processes of a second organism.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "modification of morphology or physiology of other organism"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SP1 | Sp1 transcription factor | 0.999 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.994 | Human | |
| SMAD3 | SMAD family member 3 | 0.990 | ||
| BCL2L1 | BCL2-like 1 | 0.985 | ||
| IL8 | interleukin 8 | 0.981 | ||
| RARA | retinoic acid receptor, alpha | 0.963 | ||
| SMAD7 | SMAD family member 7 | 0.960 | Human | |
| SMAD2 | SMAD family member 2 | 0.947 | Human | |
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.868 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.845 | Mouse | |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.833 | Mouse | |
| JUN | jun proto-oncogene | 0.815 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.780 | Mouse | |
| CCR5 | chemokine (C-C motif) receptor 5 | 0.762 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.754 | ||
| ESR1 | estrogen receptor 1 | 0.709 | ||
| RRAGC | Ras-related GTP binding C | 0.704 | ||
| SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.703 | ||
| BAX | BCL2-associated X protein | 0.676 | Human | |
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.629 | Mouse | |
| NCOA1 | nuclear receptor coactivator 1 | 0.613 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.576 | Human | |
| SOX10 | SRY (sex determining region Y)-box 10 | 0.513 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.488 | ||
| CREBBP | CREB binding protein | 0.448 | Human | |
| HMGA1 | high mobility group AT-hook 1 | 0.440 | Human | |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.426 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.416 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.415 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.414 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.414 | Human | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.407 | ||
| SMARCA4 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 | 0.405 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.398 | ||
| AR | androgen receptor | 0.373 | ||
| UTRN | utrophin | 0.347 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.334 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.328 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.304 | ||
| MED25 | mediator complex subunit 25 | 0.302 | ||
| RXRA | retinoid X receptor, alpha | 0.287 | ||
| IL1B | interleukin 1, beta | 0.286 | ||
| SKIL | SKI-like oncogene | 0.284 | ||
| ANG | angiogenin, ribonuclease, RNase A family, 5 | 0.245 | Human | |
| SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 0.242 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.216 | Human | |
| RNASE4 | ribonuclease, RNase A family, 4 | 0.213 | Human | |
| CXCL6 | chemokine (C-X-C motif) ligand 6 (granulocyte chemotactic protein 2) | 0.211 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.198 | ||
| ARID1B | AT rich interactive domain 1B (SWI1-like) | 0.194 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.184 | ||
| DMD | dystrophin | 0.165 | ||
| FOXD3 | forkhead box D3 | 0.144 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.142 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.137 | ||
| EP300 | E1A binding protein p300 | 0.130 | ||
| ATF3 | activating transcription factor 3 | 0.130 | ||
| SMAD1 | SMAD family member 1 | 0.123 | Human | |
| CCL3 | chemokine (C-C motif) ligand 3 | 0.123 | ||
| IRS1 | insulin receptor substrate 1 | 0.122 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.118 | Mouse | |
| SRGN | serglycin | 0.117 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.116 | Human | |
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.115 | ||
| BAD | BCL2-associated agonist of cell death | 0.114 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.112 | ||
| SS18 | synovial sarcoma translocation, chromosome 18 | 0.111 | ||
| KDM6A | lysine (K)-specific demethylase 6A | 0.106 | ||
| YY1 | YY1 transcription factor | 0.106 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.105 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.100 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.098 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.097 | ||
| JUNB | jun B proto-oncogene | 0.094 | Human | |
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.093 | ||
| SFPQ | splicing factor proline/glutamine-rich | 0.091 | ||
| ARID2 | AT rich interactive domain 2 (ARID, RFX-like) | 0.090 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.090 | ||
| RBBP4 | retinoblastoma binding protein 4 | 0.089 | ||
| MPO | myeloperoxidase | 0.086 | ||
| LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | 0.086 | ||
| SPOP | speckle-type POZ protein | 0.084 | ||
| SMAD5 | SMAD family member 5 | 0.083 | Human | |
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.082 | ||
| TCF4 | transcription factor 4 | 0.082 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.077 | Human | |
| PROX1 | prospero homeobox 1 | 0.077 | ||
| LAT | linker for activation of T cells | 0.075 | ||
| RRAGD | Ras-related GTP binding D | 0.074 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.074 | Human | |
| CCL20 | chemokine (C-C motif) ligand 20 | 0.073 | Human | |
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.071 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.069 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.068 | ||
| SMAD4 | SMAD family member 4 | 0.067 | Human | |
| RAB6A | RAB6A, member RAS oncogene family | 0.067 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.067 | ||
| TOP1 | topoisomerase (DNA) I | 0.066 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.065 | ||
| TNF | tumor necrosis factor | 0.065 | ||
| IL10 | interleukin 10 | 0.062 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.059 | Human | |
| AZU1 | azurocidin 1 | 0.059 | ||
| CCR3 | chemokine (C-C motif) receptor 3 | 0.059 | ||
| CCL5 | chemokine (C-C motif) ligand 5 | 0.058 | ||
| JUND | jun D proto-oncogene | 0.057 | Human | |
| PSEN1 | presenilin 1 | 0.056 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.056 | Human | |
| MAGEB18 | melanoma antigen family B, 18 | 0.053 | ||
| ENG | endoglin | 0.053 | ||
| GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 0.053 | ||
| CCL7 | chemokine (C-C motif) ligand 7 | 0.052 | Human | |
| RNR2 | l-rRNA | 0.052 | ||
| BID | BH3 interacting domain death agonist | 0.051 | ||
| RAB5A | RAB5A, member RAS oncogene family | 0.051 | ||
| IL2RB | interleukin 2 receptor, beta | 0.050 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.050 | ||
| PPP2R2B | protein phosphatase 2, regulatory subunit B, beta | 0.050 | ||
| RNASE3 | ribonuclease, RNase A family, 3 | 0.049 | Human | |
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.049 | ||
| PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.049 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.049 | ||
| IDE | insulin-degrading enzyme | 0.048 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.048 | Human | |
| EGR1 | early growth response 1 | 0.046 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.046 | ||
| APOL1 | apolipoprotein L, 1 | 0.045 | ||
| THBS1 | thrombospondin 1 | 0.045 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.044 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.043 | ||
| FOSL1 | FOS-like antigen 1 | 0.043 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.042 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.041 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.041 | ||
| IRF4 | interferon regulatory factor 4 | 0.041 | ||
| ESRRG | estrogen-related receptor gamma | 0.039 | ||
| APOC3 | apolipoprotein C-III | 0.039 | ||
| RUNX3 | runt-related transcription factor 3 | 0.038 | ||
| OCIAD1 | OCIA domain containing 1 | 0.038 | ||
| MMP12 | matrix metallopeptidase 12 (macrophage elastase) | 0.038 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.038 | ||
| CCR2 | chemokine (C-C motif) receptor 2 | 0.037 | ||
| RNF11 | ring finger protein 11 | 0.037 | ||
| JUP | junction plakoglobin | 0.037 | ||
| DTNA | dystrobrevin, alpha | 0.036 | ||
| ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.036 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.036 | ||
| ATF2 | activating transcription factor 2 | 0.036 | Human | |
| MECP2 | methyl CpG binding protein 2 (Rett syndrome) | 0.036 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.036 | ||
| RAB14 | RAB14, member RAS oncogene family | 0.036 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.036 | ||
| APOA2 | apolipoprotein A-II | 0.035 | ||
| RNH1 | ribonuclease/angiogenin inhibitor 1 | 0.035 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.035 | ||
| CLEC4D | C-type lectin domain family 4, member D | 0.035 | Human | |
| CCR4 | chemokine (C-C motif) receptor 4 | 0.035 | ||
| CCL17 | chemokine (C-C motif) ligand 17 | 0.034 | Human | |
| ICAM1 | intercellular adhesion molecule 1 | 0.034 | ||
| FPR3 | formyl peptide receptor 3 | 0.034 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.033 | ||
| APOC1 | apolipoprotein C-I | 0.033 | ||
| HIC1 | hypermethylated in cancer 1 | 0.033 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.033 | ||
| IL1A | interleukin 1, alpha | 0.032 | ||
| HTT | huntingtin | 0.032 | ||
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.032 | ||
| BBC3 | BCL2 binding component 3 | 0.031 | ||
| FAM46A | family with sequence similarity 46, member A | 0.031 | ||
| SMAD6 | SMAD family member 6 | 0.031 | Human | |
| TAF13 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa | 0.031 | ||
| APOL2 | apolipoprotein L, 2 | 0.031 | Human | |
| APOE | apolipoprotein E | 0.031 | ||
| CH25H | cholesterol 25-hydroxylase | 0.031 | ||
| IER2 | immediate early response 2 | 0.031 | ||
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.030 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.029 | ||
| POU2F1 | POU class 2 homeobox 1 | 0.029 | Human | |
| PRTN3 | proteinase 3 | 0.029 | ||
| RNF144B | ring finger protein 144B | 0.029 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.029 | ||
| GOLGA1 | golgin A1 | 0.029 | ||
| INHBA | inhibin, beta A | 0.029 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.029 | ||
| DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 0.029 | ||
| CTSG | cathepsin G | 0.028 | Mouse | |
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.028 | ||
| SMARCA2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 0.028 | Human | |
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.028 | ||
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.028 | ||
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.028 | ||
| VAPB | VAMP (vesicle-associated membrane protein)-associated protein B and C | 0.028 | ||
| TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.028 | ||
| SELE | selectin E | 0.027 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.027 | ||
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | 0.027 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.027 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.027 | ||
| APOA1 | apolipoprotein A-I | 0.027 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.027 | ||
| TP53 | tumor protein p53 | 0.027 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.027 | ||
| HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.027 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.027 | ||
| CD83 | CD83 molecule | 0.026 | ||
| DEFA4 | defensin, alpha 4, corticostatin | 0.026 | ||
| CIITA | class II, major histocompatibility complex, transactivator | 0.026 | ||
| NKG7 | natural killer cell group 7 sequence | 0.026 | ||
| HMOX2 | heme oxygenase (decycling) 2 | 0.026 | ||
| MMP9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | 0.026 | Rat | |
| CYBA | cytochrome b-245, alpha polypeptide | 0.025 | ||
| EBI3 | Epstein-Barr virus induced 3 | 0.025 | ||
| CD209 | CD209 molecule | 0.025 | Human | |
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.025 | ||
| CXCR6 | chemokine (C-X-C motif) receptor 6 | 0.025 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.025 | ||
| BMP2 | bone morphogenetic protein 2 | 0.025 | ||
| FSTL1 | follistatin-like 1 | 0.025 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.024 | ||
| CST7 | cystatin F (leukocystatin) | 0.024 | ||
| HP | haptoglobin | 0.024 | ||
| MS4A3 | membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific) | 0.024 | ||
| IER3 | immediate early response 3 | 0.024 | ||
| ZC3H12A | zinc finger CCCH-type containing 12A | 0.024 | ||
| RARRES3 | retinoic acid receptor responder (tazarotene induced) 3 | 0.024 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.024 | ||
| CXXC5 | CXXC finger protein 5 | 0.024 | ||
| APOC2 | apolipoprotein C-II | 0.024 | ||
| CCR1 | chemokine (C-C motif) receptor 1 | 0.023 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.023 | ||
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 0.023 | ||
| RCOR1 | REST corepressor 1 | 0.023 | ||
| BATF2 | basic leucine zipper transcription factor, ATF-like 2 | 0.023 | ||
| DNASE1L3 | deoxyribonuclease I-like 3 | 0.023 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.023 | ||
| PRG2 | proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) | 0.023 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.023 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.023 | ||
| CLEC4E | C-type lectin domain family 4, member E | 0.023 | Human | |
| PLA2G7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 0.023 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.023 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.022 | ||
| BCL2A1 | BCL2-related protein A1 | 0.022 | ||
| CFB | complement factor B | 0.022 | ||
| OSBPL9 | oxysterol binding protein-like 9 | 0.022 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.022 | ||
| CAV2 | caveolin 2 | 0.022 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.022 | ||
| RHOB | ras homolog gene family, member B | 0.022 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.022 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.021 | ||
| HNF1A | HNF1 homeobox A | 0.021 | ||
| ELANE | elastase, neutrophil expressed | 0.021 | Mouse | |
| A2M | alpha-2-macroglobulin | 0.021 | ||
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 0.021 | ||
| GHR | growth hormone receptor | 0.021 | ||
| PPARG | peroxisome proliferator-activated receptor gamma | 0.021 | ||
| IL7R | interleukin 7 receptor | 0.021 | ||
| IRS2 | insulin receptor substrate 2 | 0.021 | ||
| LAMC3 | laminin, gamma 3 | 0.020 | ||
| GLTPD1 | glycolipid transfer protein domain containing 1 | 0.020 | ||
| ARID1A | AT rich interactive domain 1A (SWI-like) | 0.020 | ||
| TBC1D17 | TBC1 domain family, member 17 | 0.020 | ||
| BATF | basic leucine zipper transcription factor, ATF-like | 0.020 | ||
| NFYC | nuclear transcription factor Y, gamma | 0.020 | ||
| ACVR2B | activin A receptor, type IIB | 0.020 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.020 | ||
| MEP1A | meprin A, alpha (PABA peptide hydrolase) | 0.020 | ||
| IK | IK cytokine, down-regulator of HLA II | 0.019 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.019 | ||
| CRP | C-reactive protein, pentraxin-related | 0.019 | Human | |
| ICOS | inducible T-cell co-stimulator | 0.019 | ||
| BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | 0.019 | ||
| RBBP7 | retinoblastoma binding protein 7 | 0.019 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.019 | ||
| IFNG | interferon, gamma | 0.018 | ||
| VAPA | VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa | 0.018 | Human | |
| PBRM1 | polybromo 1 | 0.018 | ||
| TIAL1 | TIA1 cytotoxic granule-associated RNA binding protein-like 1 | 0.018 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.018 | ||
| DARC | Duffy blood group, chemokine receptor | 0.018 | ||
| SLAMF8 | SLAM family member 8 | 0.018 | ||
| HPX | hemopexin | 0.018 | ||
| CCL23 | chemokine (C-C motif) ligand 23 | 0.018 | Human | |
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | 0.018 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.018 | ||
| MED1 | mediator complex subunit 1 | 0.018 | ||
| MMP8 | matrix metallopeptidase 8 (neutrophil collagenase) | 0.018 | ||
| MSC | musculin | 0.018 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.018 | ||
| CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.018 | ||
| INADL | InaD-like (Drosophila) | 0.018 | ||
| BPI | bactericidal/permeability-increasing protein | 0.018 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.018 | ||
| NOTCH1 | notch 1 | 0.018 | ||
| RXRB | retinoid X receptor, beta | 0.018 | Human | |
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.018 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.018 | ||
| HOXA9 | homeobox A9 | 0.018 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.018 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.018 | ||
| FBXL15 | F-box and leucine-rich repeat protein 15 | 0.017 | ||
| CLC | Charcot-Leyden crystal protein | 0.017 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.017 | ||
| IL32 | interleukin 32 | 0.017 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.017 | ||
| TCF12 | transcription factor 12 | 0.017 | ||
| CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.017 | ||
| MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 0.017 | ||
| SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.017 | ||
| PTBP2 | polypyrimidine tract binding protein 2 | 0.017 | ||
| HSF2 | heat shock transcription factor 2 | 0.017 | ||
| CTSE | cathepsin E | 0.017 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.017 | ||
| WBP4 | WW domain binding protein 4 (formin binding protein 21) | 0.017 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.016 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.016 | ||
| GFI1 | growth factor independent 1 transcription repressor | 0.016 | ||
| SLC2A5 | solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | 0.016 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.016 | ||
| IL11 | interleukin 11 | 0.016 | ||
| EPOR | erythropoietin receptor | 0.016 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.016 | ||
| BCL2L2 | BCL2-like 2 | 0.016 | Human | |
| CD80 | CD80 molecule | 0.016 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.016 | ||
| IL21R | interleukin 21 receptor | 0.016 | ||
| CPN1 | carboxypeptidase N, polypeptide 1 | 0.016 | ||
| ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | 0.016 | ||
| F2 | coagulation factor II (thrombin) | 0.016 | ||
| FAM107A | family with sequence similarity 107, member A | 0.016 | ||
| LCN2 | lipocalin 2 | 0.016 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.015 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.015 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.015 | Rat | |
| PI3 | peptidase inhibitor 3, skin-derived | 0.015 | ||
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.015 | ||
| MMP10 | matrix metallopeptidase 10 (stromelysin 2) | 0.015 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.015 | ||
| TRPV6 | transient receptor potential cation channel, subfamily V, member 6 | 0.015 | ||
| TTR | transthyretin | 0.015 | ||
| FCN1 | ficolin (collagen/fibrinogen domain containing) 1 | 0.015 | ||
| MARCO | macrophage receptor with collagenous structure | 0.015 | ||
| IGF2BP1 | insulin-like growth factor 2 mRNA binding protein 1 | 0.015 | ||
| SLAMF7 | SLAM family member 7 | 0.015 | ||
| DACH1 | dachshund homolog 1 (Drosophila) | 0.015 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.015 | ||
| PURB | purine-rich element binding protein B | 0.015 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.015 | ||
| GPR97 | G protein-coupled receptor 97 | 0.015 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.015 | ||
| LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.015 | ||
| PIAS1 | protein inhibitor of activated STAT, 1 | 0.015 | ||
| CAMP | cathelicidin antimicrobial peptide | 0.014 | ||
| IL3 | interleukin 3 (colony-stimulating factor, multiple) | 0.014 | ||
| CCL3L3 | chemokine (C-C motif) ligand 3-like 3 | 0.014 | ||
| FCAR | Fc fragment of IgA, receptor for | 0.014 | ||
| VDAC1 | voltage-dependent anion channel 1 | 0.014 | ||
| APOA4 | apolipoprotein A-IV | 0.014 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.014 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.014 | Human | |
| KANK2 | KN motif and ankyrin repeat domains 2 | 0.014 | ||
| CLEC10A | C-type lectin domain family 10, member A | 0.014 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.014 | ||
| ELN | elastin | 0.014 | ||
| AFF2 | AF4/FMR2 family, member 2 | 0.014 | ||
| BCL11A | B-cell CLL/lymphoma 11A (zinc finger protein) | 0.014 | ||
| ZFYVE1 | zinc finger, FYVE domain containing 1 | 0.014 | ||
| LTF | lactotransferrin | 0.014 | ||
| PAX3 | paired box 3 | 0.014 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.014 | ||
| JDP2 | Jun dimerization protein 2 | 0.014 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.014 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.014 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.014 | ||
| INSR | insulin receptor | 0.014 | ||
| ASGR1 | asialoglycoprotein receptor 1 | 0.014 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.014 | Human | |
| CLU | clusterin | 0.014 | ||
| CCBP2 | chemokine binding protein 2 | 0.014 | ||
| ATP6V1E1 | ATPase, H+ transporting, lysosomal 31kDa, V1 subunit E1 | 0.013 | ||
| PTX3 | pentraxin 3, long | 0.013 | ||
| CLEC5A | C-type lectin domain family 5, member A | 0.013 | ||
| CCND3 | cyclin D3 | 0.013 | ||
| CD69 | CD69 molecule | 0.013 | ||
| CMA1 | chymase 1, mast cell | 0.013 | ||
| APCS | amyloid P component, serum | 0.013 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.013 | ||
| SQSTM1 | sequestosome 1 | 0.013 | ||
| TRIM33 | tripartite motif containing 33 | 0.013 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.013 | ||
| CD40LG | CD40 ligand | 0.013 | ||
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | 0.013 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.013 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.013 | ||
| ONECUT1 | one cut homeobox 1 | 0.013 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.013 | ||
| DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 0.013 | ||
| EREG | epiregulin | 0.013 | ||
| AXIN1 | axin 1 | 0.013 | ||
| S100A9 | S100 calcium binding protein A9 | 0.013 | ||
| HIPK3 | homeodomain interacting protein kinase 3 | 0.013 | ||
| LTK | leukocyte receptor tyrosine kinase | 0.013 | Human | |
| FGA | fibrinogen alpha chain | 0.013 | ||
| ZDHHC17 | zinc finger, DHHC-type containing 17 | 0.013 | ||
| ALOX15 | arachidonate 15-lipoxygenase | 0.013 | ||
| RFX1 | regulatory factor X, 1 (influences HLA class II expression) | 0.013 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.013 | ||
| SIRT1 | sirtuin 1 | 0.013 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.013 | ||
| TBX2 | T-box 2 | 0.013 | ||
| HLA-DQB1 | major histocompatibility complex, class II, DQ beta 1 | 0.013 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.013 | ||
| SERPINB10 | serpin peptidase inhibitor, clade B (ovalbumin), member 10 | 0.013 | ||
| DBN1 | drebrin 1 | 0.013 | ||
| IL18R1 | interleukin 18 receptor 1 | 0.013 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.013 | ||
| PTGIR | prostaglandin I2 (prostacyclin) receptor (IP) | 0.013 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.013 | ||
| PARVA | parvin, alpha | 0.013 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.013 | ||
| KDM6B | lysine (K)-specific demethylase 6B | 0.013 | ||
| IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 0.013 | ||
| PRG3 | proteoglycan 3 | 0.012 | ||
| G0S2 | G0/G1switch 2 | 0.012 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.012 | ||
| CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 | 0.012 | ||
| NR2F1 | nuclear receptor subfamily 2, group F, member 1 | 0.012 | Human | |
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.012 | Human | |
| CA1 | carbonic anhydrase I | 0.012 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.012 | ||
| MUC4 | mucin 4, cell surface associated | 0.012 | ||
| THAP11 | THAP domain containing 11 | 0.012 | ||
| MMP19 | matrix metallopeptidase 19 | 0.012 | ||
| EMD | emerin | 0.012 | ||
| NKX2-1 | NK2 homeobox 1 | 0.012 | ||
| C1R | complement component 1, r subcomponent | 0.012 | ||
| SH3RF3 | SH3 domain containing ring finger 3 | 0.012 | ||
| TPSB2 | tryptase beta 2 (gene/pseudogene) | 0.012 | ||
| UTY | ubiquitously transcribed tetratricopeptide repeat gene, Y-linked | 0.012 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.012 | Human | |
| UBD | ubiquitin D | 0.012 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.012 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.012 | ||
| C1S | complement component 1, s subcomponent | 0.012 | ||
| NNMT | nicotinamide N-methyltransferase | 0.012 | ||
| HOXA1 | homeobox A1 | 0.012 | ||
| POU3F3 | POU class 3 homeobox 3 | 0.012 | Human | |
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.012 | ||
| LAMP3 | lysosomal-associated membrane protein 3 | 0.012 | ||
| USP9X | ubiquitin specific peptidase 9, X-linked | 0.012 | ||
| RAB8A | RAB8A, member RAS oncogene family | 0.012 | ||
| LEP | leptin | 0.012 | ||
| FPR2 | formyl peptide receptor 2 | 0.012 | ||
| STAU1 | staufen, RNA binding protein, homolog 1 (Drosophila) | 0.012 | ||
| TOP2B | topoisomerase (DNA) II beta 180kDa | 0.012 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.012 | ||
| SP3 | Sp3 transcription factor | 0.012 | Human | |
| AP1G1 | adaptor-related protein complex 1, gamma 1 subunit | 0.012 | ||
| CHIT1 | chitinase 1 (chitotriosidase) | 0.012 | ||
| OBSL1 | obscurin-like 1 | 0.011 | ||
| FAM114A1 | family with sequence similarity 114, member A1 | 0.011 | ||
| FGB | fibrinogen beta chain | 0.011 | ||
| C5AR1 | complement component 5a receptor 1 | 0.011 | ||
| CCL21 | chemokine (C-C motif) ligand 21 | 0.011 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.011 | ||
| DCP1A | DCP1 decapping enzyme homolog A (S. cerevisiae) | 0.011 | ||
| MEP1B | meprin A, beta | 0.011 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.011 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.011 | ||
| ACTL6A | actin-like 6A | 0.011 | ||
| CD22 | CD22 molecule | 0.011 | ||
| VEZF1 | vascular endothelial zinc finger 1 | 0.011 | ||
| IL24 | interleukin 24 | 0.011 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.011 | ||
| MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 0.011 | ||
| HOXC8 | homeobox C8 | 0.011 | ||
| CD1B | CD1b molecule | 0.011 | ||
| FUBP1 | far upstream element (FUSE) binding protein 1 | 0.011 | ||
| XCL2 | chemokine (C motif) ligand 2 | 0.011 | Human | |
| SDS | serine dehydratase | 0.011 | ||
| IL4I1 | interleukin 4 induced 1 | 0.011 | ||
| NOS2 | nitric oxide synthase 2, inducible | 0.011 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.011 | ||
| C3orf17 | chromosome 3 open reading frame 17 | 0.011 | ||
| SOD2 | superoxide dismutase 2, mitochondrial | 0.011 | ||
| SERPINA3 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | 0.011 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.011 | ||
| SIX6 | SIX homeobox 6 | 0.011 | ||
| EIF3C | eukaryotic translation initiation factor 3, subunit C | 0.011 | ||
| SRSF11 | serine/arginine-rich splicing factor 11 | 0.011 | ||
| FGG | fibrinogen gamma chain | 0.011 | ||
| CNGB1 | cyclic nucleotide gated channel beta 1 | 0.011 | ||
| ZFP36L2 | zinc finger protein 36, C3H type-like 2 | 0.011 | ||
| NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.011 | ||
| EMR3 | egf-like module containing, mucin-like, hormone receptor-like 3 | 0.011 | ||
| OR2T6 | olfactory receptor, family 2, subfamily T, member 6 | 0.011 | ||
| SHBG | sex hormone-binding globulin | 0.011 | ||
| OSM | oncostatin M | 0.011 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.011 | ||
| ALPI | alkaline phosphatase, intestinal | 0.011 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.011 | ||
| BCOR | BCL6 corepressor | 0.011 | ||
| SSTR5 | somatostatin receptor 5 | 0.011 | ||
| BCR | breakpoint cluster region | 0.011 | ||
| EED | embryonic ectoderm development | 0.011 | ||
| SLCO2B1 | solute carrier organic anion transporter family, member 2B1 | 0.011 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.011 | ||
| BTRC | beta-transducin repeat containing | 0.011 | ||
| FUS | fused in sarcoma | 0.011 | ||
| ITGB7 | integrin, beta 7 | 0.011 | ||
| PTPN7 | protein tyrosine phosphatase, non-receptor type 7 | 0.011 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.011 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.011 | ||
| VIL1 | villin 1 | 0.011 | ||
| CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.011 | ||
| TADA3 | transcriptional adaptor 3 | 0.011 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.010 | ||
| ESRRA | estrogen-related receptor alpha | 0.010 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.010 | Human | |
| ACVR1B | activin A receptor, type IB | 0.010 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.010 | ||
| HS3ST1 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | 0.010 | ||
| GPR84 | G protein-coupled receptor 84 | 0.010 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.010 | ||
| BMP4 | bone morphogenetic protein 4 | 0.010 | ||
| ATP6V1A | ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A | 0.010 | ||
| ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.010 | ||
| GFER | growth factor, augmenter of liver regeneration | 0.010 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.010 | ||
| NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.010 | ||
| PROCR | protein C receptor, endothelial | 0.010 | ||
| GATAD2B | GATA zinc finger domain containing 2B | 0.010 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.010 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.010 | ||
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.010 | ||
| RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) | 0.010 | Human | |
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.010 | ||
| MKL2 | MKL/myocardin-like 2 | 0.010 | ||
| HDAC1 | histone deacetylase 1 | 0.010 | ||
| NOVA2 | neuro-oncological ventral antigen 2 | 0.010 | ||
| MMP7 | matrix metallopeptidase 7 (matrilysin, uterine) | 0.010 | ||
| S100A8 | S100 calcium binding protein A8 | 0.010 | ||
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.010 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.010 | ||
| ADNP | activity-dependent neuroprotector homeobox | 0.010 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.010 | ||
| FAM75A7 | family with sequence similarity 75, member A7 | 0.010 | ||
| DAZAP2 | DAZ associated protein 2 | 0.010 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.010 | ||
| GIMAP5 | GTPase, IMAP family member 5 | 0.010 | ||
| CPA3 | carboxypeptidase A3 (mast cell) | 0.010 | ||
| TACSTD2 | tumor-associated calcium signal transducer 2 | 0.010 | ||
| FOXA2 | forkhead box A2 | 0.010 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.010 | ||
| ZBTB17 | zinc finger and BTB domain containing 17 | 0.010 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.010 | ||
| CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | 0.010 |